Skip to main content

China Biotech Innovation ETF (CHB)

NASDAQ: CHB · IEX Real-Time Price · USD
16.20
0.00 (0.00%)
After-hours:Sep 24, 2021 4:15 PM EDT
16.20
-0.16 (-0.95%)
At close: Sep 24, 4:00 PM
Assets$5.07M
NAV$16.36
Expense Ratio0.67%
PE Ratio121.45
Shares Out310,000
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
1-Year Return
-
Volume790
Open16.28
Previous Close16.36
Day's Range16.10 - 16.36
52-Week Low14.75
52-Week High20.17
Beta-3.50
Holdings35
Inception DateSep 22, 2020

About CHB

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index (underlying index). The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China's biotechnology industry. It is non-diversified.

Asset ClassEquity
IssuerGlobal X Mgt
Stock ExchangeNASDAQ
Ticker SymbolCHB
Index TrackedSolactive China Biotech Innovation Index

Top 10 Holdings

61.52% of assets
NameSymbolWeight
WALVAX BIOTECHNOLOGY CO-AN/A10.36%
BeiGeneBGNE10.20%
WUXI BIOLOGICS CAYMAN INC2269.HK10.15%
SHENZHEN KANGT-AN/A5.96%
CHANGCHUN HIGH-AN/A4.51%
PHARMABLOCK SC-AN/A4.37%
GENSCRIPT BIOTECH CORP1548.HK4.13%
ZHEJIANG WOLWO-AN/A4.12%
SINO BIOPHARMACEUTICAL1177.HK3.95%
BGI GENOMICS CO LTD-AN/A3.77%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Jun 29, 2021$0.00Jul 8, 2021
Full Dividend History

News

5 Top-Performing ETFs of Last Week

Wall Street was downbeat last week on inflationary concerns and some downbeat economic data points.

Other symbols:CHIHEPUKURE
4 months ago - Zacks Investment Research

The CHB ETF: China's Burgeoning Biotech Sector

As China continues to lead the global recovery, one area to keep a close eye on is biotechnology and the Global X China Biotech Innovation ETF (CHB). CHB seeks to provide investment results that corresp...

4 months ago - ETF Trends

Are Healthcare ETFs Poised for a Comeback?

Decent earnings growth picture and valuation as well as solid deals activities have been favoring healthcare sector at the current level.

5 months ago - Zacks Investment Research

ETF Odds & Ends: First Mutual Fund Conversion

Plus, iShares lowered expense ratios on two of its ETFs.

Other symbols:AMLPGOVTJMUBUSIGVFLQ
5 months ago - ETFcom

3 Biotech Stocks With Eye-Catching Pipelines

Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist. The post 3 Biotech Stocks With Eye-Catching Pipelines appeared first on InvestorP...

Other symbols:ABBVRPRX
10 months ago - InvestorPlace

China's Quest for a Covid-19 Vaccine Could Help Boost This ETF

All around the world, economic superpowers are vying to be the first to develop a vaccine for Covid-19. China is an obvious contender given that the country was the epicenter of the virus and their succ...

11 months ago - ETF Trends